VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
LTRN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
LTRNLantern Pharma Inc.
$4.07$52M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksLTRNQuarterly Financials

Lantern Pharma Inc. (LTRN) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Lantern Pharma Inc. (LTRN) quarterly income statement — complete revenue, gross profit & net income history

LTRN Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold3.85K000051.22K00044.32K0000000000
COGS % of Revenue--------------------
Gross Profit-3.85K0000-51.22K000-44.32K0000000000
Gross Margin %--------------------
Gross Profit Growth %-100%----15.59%--------------
Operating Expenses3.4M4.2M4.35M4.65M4.77M5.85M5.18M5.41M5.73M4.83M3.52M5.19M4.29M3.83M2.15M4.39M4.07M3.51M4.15M2.48M
OpEx % of Revenue--------------------
Selling, General & Admin1.68M1.46M1.91M1.58M1.51M1.58M1.46M1.52M1.48M1.26M1.31M1.63M1.73M1.57M1.44M1.41M1.41M1.35M1.18M1.31M
SG&A % of Revenue--------------------
Research & Development1.72M2.74M2.44M3.07M3.26M4.27M3.72M3.89M4.25M3.57M2.21M3.56M2.55M2.25M702.3K2.99M2.66M2.16M2.96M1.16M
R&D % of Revenue--------------------
Other Operating Expenses00000000000000000000
Operating Income-3.41M-4.2M-4.35M-4.65M-4.77M-5.9M-5.18M-5.41M-5.73M-4.88M-3.52M-5.19M-4.29M-3.83M-2.15M-4.39M-4.07M-3.51M-4.15M-2.48M
Operating Margin %--------------------
Operating Income Growth %28.67%28.72%16.02%13.99%16.71%-20.89%-47%-4.2%-33.73%-27.47%-64.25%-18.1%-5.41%-8.97%48.29%-77.28%-65.82%-21.24%-143.84%-197.46%
EBITDA-3.4M-4.2M-4.35M-4.65M-4.77M-5.85M-5.18M-5.4M-5.73M-4.83M-3.52M-5.19M-4.28M-3.82M-2.14M-4.39M-4.06M-3.51M-4.15M-2.48M
EBITDA Margin %--------------------
EBITDA Growth %28.68%28.17%16.03%14%16.73%-20.94%-47.03%-4.19%-33.74%-26.4%-64.3%-18.08%-5.37%-8.96%48.34%-77.29%-65.83%-21.22%-143.89%-197.51%
D&A (Non-Cash Add-back)3.85K4.1K4.1K4.5K4.57K51.22K4.39K4.26K4.06K44.32K3.71K3.51K3.42K2.76K2.95K2.38K1.99K1.99K1.85K1.58K
EBIT-3.41M-4.2M-4.35M-4.65M-4.77M-5.88M-5.18M-5.41M-5.73M-4.19M-3.52M-5.19M-4.29M-3.83M-2.15M-4.39M-4.07M-2.51M-4.15M-2.48M
Net Interest Income42.16K72.47K100.92K114.75K149.79K161.39K191.35K188.66K200.95K267.39K246.39K117.82K133.78K74.68K52.22K55.03K22.42K-57.18K77.22K47.89K
Interest Income42.16K72.47K100.92K114.75K149.79K161.39K191.35K188.66K200.95K267.39K246.39K117.82K133.78K74.68K52.22K55.03K22.42K-57.18K77.22K47.89K
Interest Expense00000000000000000000
Other Income/Expense76.08K128.54K172.38K320.88K237.25K21.2K673.88K448.95K291.19K691.46K362.17K443.9K418.5K445.17K-119.42K-97.56K-55.38K-29.03K94.9K162.61K
Pretax Income-3.33M-4.07M-4.18M-4.33M-4.54M-5.88M-4.51M-4.96M-5.44M-4.19M-3.16M-4.75M-3.87M-3.38M-2.26M-4.49M-4.12M-3.54M-4.05M-2.32M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-3.33M-4.07M-4.18M-4.33M-4.54M-5.88M-4.51M-4.96M-5.44M-4.19M-3.16M-4.75M-3.87M-3.38M-2.26M-4.49M-4.12M-3.54M-4.05M-2.32M
Net Margin %--------------------
Net Income Growth %26.62%30.65%7.29%12.67%16.62%-40.36%-42.52%-4.49%-40.67%-23.8%-39.6%-5.65%6.16%4.5%44.14%-93.93%-68.08%-22.25%-138.26%-177.95%
Net Income (Continuing)-3.33M-4.07M-4.18M-4.33M-4.54M-5.88M-4.51M-4.96M-5.44M-4.19M-3.16M-4.75M-3.87M-3.38M-2.26M-4.49M-4.12M-3.54M-4.05M-2.32M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.30-0.36-0.39-0.40-0.42-0.54-0.42-0.46-0.51-0.39-0.29-0.44-0.32-0.31-0.22-0.42-0.38-0.32-0.36-0.21
EPS Growth %28.57%33.33%7.14%13.04%17.65%-38.46%-44.83%-4.55%-59.38%-25.81%-31.82%-4.76%15.79%3.13%38.89%-100%-58.33%31.91%-33.33%-50%
EPS (Basic)-0.30-0.36-0.39-0.40-0.42-0.54-0.42-0.46-0.51-0.39-0.29-0.44-0.32-0.31-0.22-0.42-0.38-0.32-0.36-0.21
Diluted Shares Outstanding11.25M10.9M10.83M10.78M10.78M10.78M10.76M10.76M10.74M10.8M10.86M10.86M10.86M10.85M10.84M10.83M10.88M11.19M11.19M11.18M
Basic Shares Outstanding11.25M10.9M10.83M10.78M10.78M10.78M10.76M10.76M10.74M10.8M10.86M10.86M10.86M10.85M10.84M10.83M10.88M11.17M11.19M11.18M
Dividend Payout Ratio--------------------